Study of MeRes100 in the Treatment of Patient With Coronary Artery Disease.

NCT03454724 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

484

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: MeRes100 Sirolimus-Eluting BioResorbable Vascular Scaffold System
DEVICE: Xience EES Everolimus Eluting Coronary Stent System

Sponsor

Meril Life Sciences Pvt. Ltd.